Author:
Neves Maria,Teixeira Fátima C.,Antunes Inês,Majkowska Agnieszka,Gano Lurdes,Santos Ana Cristina
Reference18 articles.
1. New results from the use of bisphosphonates in cancer patients;Coleman;Curr. Opin. Support Palliat. Care,2009
2. Molecular modeling of the interaction of novel hydroxy and aminobisphosphonates with hydroxyapatite;Duarte;ARKIVOC,2010
3. Therapeutic radiopharmaceuticals;Ercan;Curr Pharm Design,2000
4. Cross-fire doses from β-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics;Enger;Phys. Med. Biol.,2008
5. Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases;Francis;J. Musculoskelet. Neuronal.Interact.,2007
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DEVELOPMENT AND ESTIMATION OF HUMAN DOSIMETRY OF A NEW 47SC-RISEDRONATE FOR RADIOPHARMACEUTICAL APPLICATION;Radiation Protection Dosimetry;2022-09-24
2. Synthesis of Diorganylphosphine Oxides Bearing Hetarylalkyl Moieties and Study of Their Antimicrobial Activities;ChemistrySelect;2022-09-13
3. Novel Bisphosphonates Derived from 1H-Indazole, 1H-Pyrazolo[3,4-b]Pyridine, and 1H-Pyrazolo[3,4-b]Quinoline;Heteroatom Chemistry;2015-10-12
4. Production, biodistribution, and dosimetry of47Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical;Journal of Medical Physics;2015
5. Review of Advances in Planar Radiochromatography;Journal of Liquid Chromatography & Related Technologies;2014-10-31